Literature DB >> 15225251

Different susceptibility of B19 virus and mice minute virus to low pH treatment.

Nicola Boschetti1, Isabel Niederhauser, Christoph Kempf, Albert Stühler, Johannes Löwer, Johannes Blümel.   

Abstract

BACKGROUND: Parvoviridae are small nonenveloped viruses that are known to be highly resistant to physico-chemical treatments. Because low pH is frequently applied to process intermediates or final products, the impact of such conditions on the human erythrovirus B19 (B19V) and the mouse parvovirus (mice minute virus, MMV) was assessed, which is often used as a model for B19V. Owing to the lack of a suitable cultivation and/or detection system for B19V no such data exist so far. STUDY DESIGN AND METHODS: Virus inactivation was monitored by decrease of infectivity and loss of capsid integrity. Infectious B19V was quantified by detection of virus-specific messenger RNA from Ku812Ep6 cells. To measure capsid integrity, endonucleases were added after exposure to low pH and the encapsidated (endonuclease-protected) virus DNA was quantified by real-time PCR.
RESULTS: B19V was inactivated greater than 5 log after 2 hours at pH 4, whereas MMV was resistant over 9 hours. Infectivity data strongly correlated with data obtained by the endonuclease assay. Capsid disintegration was observed in immunoglobulin G as well as in different albumin solutions. Temperature and pH showed concerted impact on B19V capsid disintegration.
CONCLUSION: Our data show that B19V is much more vulnerable toward low pH conditions than MMV. Together with the previously reported susceptibility of B19V toward wet heat conditions, low pH is the second treatment where erythrovirus B19V is less resistant than viruses from the parvovirus genus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225251     DOI: 10.1111/j.1537-2995.2004.03420.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  11 in total

1.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

2.  Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.

Authors:  Johannes Blümel; Anna Maria Eis-Hübinger; Albert Stühler; Claudia Bönsch; Matthias Gessner; Johannes Löwer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Transmission of mouse parvovirus by fomites.

Authors:  Susan R Compton; Frank X Paturzo; Peter C Smith; James D Macy
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-11       Impact factor: 1.232

4.  Transmission probabilities of mouse parvovirus 1 to sentinel mice chronically exposed to serial dilutions of contaminated bedding.

Authors:  David G Besselsen; Erin L Myers; Craig L Franklin; Scott W Korte; April M Wagner; Kenneth S Henderson; Benjamin J Weigler
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

5.  Effect of Cage-Wash Temperature on the Removal of Infectious Agents from Caging and the Detection of Infectious Agents on the Filters of Animal Bedding-Disposal Cabinets by PCR Analysis.

Authors:  Susan R Compton; James D Macy
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-11       Impact factor: 1.232

6.  Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking.

Authors:  Bridget Lins-Austin; Saajan Patel; Mario Mietzsch; Dewey Brooke; Antonette Bennett; Balasubramanian Venkatakrishnan; Kim Van Vliet; Adam N Smith; Joanna R Long; Robert McKenna; Mark Potter; Barry Byrne; Sanford L Boye; Brian Bothner; Regine Heilbronn; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2020-06-20       Impact factor: 5.048

Review 7.  Virus safety of intravenous immunoglobulin: future challenges.

Authors:  Nicola Boschetti; Martin Stucki; Peter J Späth; Christoph Kempf
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

8.  Effective inactivation of a wide range of viruses by pasteurization.

Authors:  Albrecht Gröner; Connie Broumis; Randel Fang; Thomas Nowak; Birgit Popp; Wolfram Schäfer; Nathan J Roth
Journal:  Transfusion       Date:  2017-11-16       Impact factor: 3.157

9.  Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins.

Authors:  Christoph Kempf; Martin Stucki; Nicola Boschetti
Journal:  Biologicals       Date:  2006-04-03       Impact factor: 1.856

Review 10.  Detection and monitoring of virus infections by real-time PCR.

Authors:  F Watzinger; K Ebner; T Lion
Journal:  Mol Aspects Med       Date:  2006-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.